Eureka Bio
PrivateLast Round
Series B
Feb 21, 2024
Total Funding Raised
$54.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eureka Bio is a biotechnology company that provides automated cell processing systems and viral vector manufacturing platforms for the cell and gene therapy (CGT) industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eureka Bio Comparables
Compare Eureka Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 80% | |
| Scinogy | 77% | |
| Vector Process Innovation | 76% | |
Eureka Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 21, 2024 | ||||
| Series B | Jun 21, 2022 | ||||
| Series A | Apr 23, 2021 | ||||
| Pre Seed | Oct 1, 2020 | ||||
| Angel | Dec 1, 2018 |
Eureka Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ABC Capital | Series B |
| F-Prime Capital | Series B |
| Eight Roads Ventures | Series B |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B |
| Clearwater Bay Capital | Series B |
| Tasly Capital | Series B |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 382% MoM, reaching 1.1K.
- Feb 18, 2025
Collaborates with VectorBuilder Inc. to lower viral vector production costs.
Eureka Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eureka Bio's valuation, stock price, and market status.